title: Pharmacological profile of somatostatin and cortistatin receptors.
abstract: Somatostatin (SRIF) and cortistatin (CST) are two endogenous peptides with high sequence similarities that act as hormones/neurotransmitters both in the CNS and the periphery; their genes although distinct result from gene duplication. Their receptors appear to be common, since the five known SRIF receptors (sst1-sst5) have similar subnanomolar affinity for SRIF and CST, whether the short (SRIF-14, CST-14, CST-17) or the long versions (SRIF-28, CST-29) of the peptides. Whether CST targets specific receptors not shared by SRIF, is still debated: MrgX2 has been described as a selective CST receptor, with submicromolar affinity for CST but devoid of affinity for SRIF; however the distribution of CST and MrgX2 is largely different, and there is no MrgX2 in rodents. A similar situation arises with the GHS receptor GHS-R1a, which displays some preferential affinity for CST over SRIF, but for which there is no evidence that it is activated by CST in vivo. In both cases, one may argue that submicromolar affinity is not the norm of a GPCR for its endogenous neuropeptide. On the other hand, all receptors known to bind SRIF have similar high affinity for CST and both peptides act as potent agonists at the sst1-sst5 receptors, whichever transduction pathway is considered. In addition, [(125)I][Tyr(10)]CST(14) labels sst1-sst5 receptors with subnanomolar affinity, and [(125)I][Tyr(10)]CST(14) binding in the brain is overlapping with that of [(125)I][Tyr(0)]SRIF(14). The functional differences reported that distinguish CST from SRIF, have not been explained convincingly and may relate to ligand-driven transductional selectivity, and other complicating factors such as receptor dimerisation, (homo or heterodimerisation), and/or the influence of accessory proteins (GIPs, RAMPS), which remain to be studied in more detail.
authors.affiliation: Neuroscience Research, Novartis Institutes for BioMedical Research Basel, Basel, Switzerland.
authors.forename: Sandra
authors.initials: S
authors.lastname: Siehler
authors.forename: Caroline
authors.initials: C
authors.lastname: Nunn
authors.forename: Jason
authors.initials: J
authors.lastname: Hannon
authors.forename: Dominik
authors.initials: D
authors.lastname: Feuerbach
authors.forename: Daniel
authors.initials: D
authors.lastname: Hoyer
mesh_terms: D000818:Animals; D001667:Binding, Competitive; D006801:Humans; D009419:Nerve Tissue Proteins / Q000819:agonists / Q000378:metabolism*; D009479:Neuropeptides / Q000378:metabolism*; D055503:Protein Multimerization; D011869:Radioligand Assay; D043562:Receptors, G-Protein-Coupled / Q000819:agonists / Q000378:metabolism*; D054440:Receptors, Ghrelin / Q000378:metabolism*; D018013:Receptors, Neuropeptide / Q000819:agonists / Q000378:metabolism*; D017481:Receptors, Somatostatin / Q000819:agonists / Q000378:metabolism*; D013004:Somatostatin / Q000378:metabolism*
chemical_list: C480039:MRGPRX2 protein, human; D009419:Nerve Tissue Proteins; D009479:Neuropeptides; D043562:Receptors, G-Protein-Coupled; D054440:Receptors, Ghrelin; D018013:Receptors, Neuropeptide; D017481:Receptors, Somatostatin; C099323:cortistatin; D013004:Somatostatin